CORONA REMEDIES
|
The Current P/B Ratio of CORONA REMEDIES is 17.26.
| Share Price | ₹2,105.8 | Jul 29,2026 |
| Market Cap | ₹12,887.5 Cr | |
| Book Value | ₹746.9 Cr | Mar2026 - Consolidated Results |
| Price/Book | 17.26x | Calculated as MarketCap/Book Value |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PB (Price/Book ) ratio of CORONA REMEDIES
P/B =
Market Capitalization
/ Book Value
or, using per-share numbers:
P/B = Stock Price /
Book Value Per Share
Current Market Cap [ ₹12,887.5 Cr] as on Jul 29,2026
(/) Book Value [ ₹746.9 Cr] based on Mar2026 - Consolidated Results
(=) P/B Ratio [ 17.26x ]
Thus, for CORONA REMEDIES , the investors are currently willing to pay '17.26 times book value' to own 1 share of the company.
PB Multiples are one of the most widely used valuation multiple in industry.
Since P/B ratio uses Book Value in the calculation, P/B multiples are not always reliable for valuing companies with negative book value.
In such cases, you may consider using Price to Earnings ratio or Price to Sales ratio of CORONA REMEDIES !
The chart below summarizes the trend in P/B Ratio of CORONA REMEDIES over the last five years.
Historical PB (Price/Book ) ratio chart of CORONA REMEDIES
PB Ratio Performance Analysis for CORONA REMEDIES
- CORONA REMEDIES 's p/b ratio for fiscal years ending Mar2026 to Mar2023 averaged 3.19x.
- CORONA REMEDIES 's operated at median p/b ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 4 fiscal years, CORONA REMEDIES 's p/b ratio peaked in Mar2026 at 12.74x.
- CORONA REMEDIES 's p/b ratio hit its five-year low in Mar2025 of 0x.
How does CORONA REMEDIES 's P/B Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Book Value | PB Ratio | Market Cap |
|---|---|---|---|
| CORONA REMEDIES | 746.86 | 17.26 | 12,887.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 83,570.10 | 5.71 | 477,408.0 |
| DIVIS LABORATORIES LTD | 16,761.00 | 12.34 | 206,906.0 |
| TORRENT PHARMACEUTICALS LTD | 8,388.43 | 22.12 | 185,521.0 |
| CIPLA LTD | 34,369.40 | 3.46 | 119,032.0 |
| DR REDDYS LABORATORIES LTD | 37,742.60 | 2.53 | 95,420.1 |
| MANKIND PHARMA LTD | 16,252.60 | 6.59 | 107,071.0 |
| LUPIN LTD | 22,384.10 | 5.00 | 112,013.0 |
| ZYDUS LIFESCIENCES LTD | 27,111.40 | 4.13 | 111,960.0 |
| AUROBINDO PHARMA LTD | 37,891.00 | 2.42 | 91,531.1 |
| LAURUS LABS LTD | 5,275.08 | 18.25 | 96,264.7 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PB Analysis vs CORONA REMEDIES 's P/B Ratio
| Top 10 Industry Peers | PB Ratio |
|---|---|
| Min industry PB | 2.42x |
| Max industry PB | 22.12x |
| Median industry PB | 5.71x |
| Average industry PB | 9.07x |
You may also like the below Video Courses